Herjan J.T. Coelingh Bennink

Author

Also Known As

Bennink, Herjan J.T. Coelingh, Coelingh Bennink, H. J. T., H Bennink, H J Bennink, H J Coelingh Bennink, H. J. Coelingh Bennink, H. J. T. C. Bennink, H. J. T. COELINGH BENNINK, H. J. T. Coe-Lingh Bennink, H. J. T. Coelingh Bennink

172

Publications

4.6K

Citations

H-Index

107

Concepts

All Affiliations

Pantarhei Bioscience (Netherlands)University of Liège University Medical Center Utrecht Karolinska University Hospital Erasmus University Rotterdam

About

Herjan J.T. Coelingh Bennink is an author at Pantarhei Bioscience (Netherlands) specializing in medicine, obstetrics, and endocrinology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	26	46	1.9K
2	Public Health	17	23	1K
3	Health Sciences	3	3	53
4	Natural Sciences	1	1	12
5	Social Sciences	1	1	52

Herjan J.T. Coelingh Bennink

Publications

3.7K

Citations

H-Index

Page 1

	Year	Citations
A prospective, randomized, assessor-blind, multicentre study comparing recombinant and urinary follicle stimulating hormone (Puregon versus Metrodin) in in-vitro fertilization Henk J. Out, Bernadette Mannaerts, Stefan Driessen, Human Reproduction	1995	214
Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. B.C. Schoot, Herjan J.T. Coelingh Bennink, Bernadette Mannaerts, The Journal of Clinical Endocrinology & Metabolism FertilityHuman GrowthPreovulatory FolliclesReproductive HealthGynecology	1992	167
Endocrinology: Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women B.C. Schoot, Jonas Harlin, Zeev Shoham, Human Reproduction	1994	136
Tibolone: Influence on Markers of Cardiovascular Disease Nina Hannover Bjarnason, Ketil Bjarnason, Jens Haarbo, The Journal of Clinical Endocrinology & Metabolism	1997	116
Recombinant follicle-stimulating hormone (follitropin beta, Puregon) yields higher pregnancy rates in in vitro fertilization than urinary gonadotropins Henk J. Out, S G Driessen, Bernadette Mannaerts, Fertility and Sterility InfertilityUrinary GonadotropinsDevelopmental BiologyFertilityReproductive Health	1997	97
Differential effects on the androgen status of postmenopausal women treated with tibolone and continuous combined estradiol and norethindrone acetate replacement therapy Martina Dören, Alexander Rübig, Herjan J.T. Coelingh Bennink, Fertility and Sterility Hormonal ContraceptiveDifferential EffectsGynecologyMenopausal Hormone TherapyMenopause Hormone Therapy	2001	96
Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives. Marie Mawet, Catherine Maillard, Christine Klipping, PubMed	2015	94
Effects of two doses of tibolone on trabecular and cortical bone loss in early postmenopausal women: A two-year randomized, placebo-controlled study Bernd Berning, Cornelis van Kuijk, J. W. Kuiper, Bone Bone DiseaseTwo-year RandomizedBone HealthGynecologyEarly Postmenopausal Women	1996	86
Effects of tibolone and continuous combined hormone replacement therapy on parameters in the clotting cascade: a multicenter, double-blind, randomized study Ulrich Winkler, Rolf Altkemper, Bernadette Kwee, Fertility and Sterility ThrombosisHormone Replacement TherapyMedicineClotting CascadePlatelet Antagonist	2000	81
The effect of add-back treatment with tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl) Peter Lindsay, Robert W. Shaw, Herjan J.T. Coelingh Bennink, Fertility and Sterility Hormonal ContraceptiveEndocrine MechanismMedicineGynecologyPharmacotherapy	1996	80

Page 1